{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:27:56Z","timestamp":1769189276092,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20190201047JC"],"award-info":[{"award-number":["20190201047JC"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Health Project of Jilin Province Department of Finance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10620-020-06077-w","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T03:02:55Z","timestamp":1579834975000},"page":"3614-3623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Interleukin-35 Suppresses CD8+ T Cell Activity in Patients with Viral Hepatitis-Induced Acute-on-Chronic Liver Failure"],"prefix":"10.1007","volume":"65","author":[{"given":"Lanlan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-2907","authenticated-orcid":false,"given":"Zhenjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"6077_CR1","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0140-6736(15)00309-8","volume":"386","author":"W Bernal","year":"2015","unstructured":"Bernal W, Jalan R, Quaglia A, Simpson K, Wendon J, Burroughs A. Acute-on-chronic liver failure. Lancet. 2015;386:1576\u20131587.","journal-title":"Lancet"},{"key":"6077_CR2","first-page":"541","volume":"66","author":"R Hernaez","year":"2017","unstructured":"Hernaez R, Sola E, Moreau R, Gines P. Acute-on-chronic liver failure: an update. Gut. 2017;66:541\u2013553.","journal-title":"Acute-on-chronic liver failure: an update. Gut."},{"key":"6077_CR3","first-page":"1","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:1\u201338.","journal-title":"Hepatol Int"},{"key":"6077_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-0036-1583202","volume":"36","author":"V Arroyo","year":"2016","unstructured":"Arroyo V, Jalan R. Acute-on-Chronic liver failure: definition, diagnosis, and clinical characteristics. Semin Liver Dis. 2016;36:109\u2013116.","journal-title":"Semin Liver Dis"},{"key":"6077_CR5","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.3748\/wjg.v21.i42.12125","volume":"21","author":"S Blasco-Algora","year":"2015","unstructured":"Blasco-Algora S, Masegosa-Ataz J, Gutierrez-Garcia ML, Alonso-Lopez S, Fernandez-Rodriguez CM. Acute-on-chronic liver failure: pathogenesis, prognostic factors and management. World J Gastroenterol. 2015;21:12125\u201312140.","journal-title":"World J Gastroenterol"},{"key":"6077_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-0038-1672201","volume":"39","author":"MK Hensley","year":"2018","unstructured":"Hensley MK, Deng JC. Acute on chronic liver failure and immune dysfunction: a mimic of sepsis. Semin Respir Crit Care Med. 2018;39:588\u2013597.","journal-title":"Semin Respir Crit Care Med"},{"key":"6077_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450:566\u2013569.","journal-title":"Nature"},{"key":"6077_CR8","first-page":"7948687","volume":"2019","author":"T Wang","year":"2019","unstructured":"Wang T, Mei Y, Li Z. Research progress on regulatory B cells in systemic lupus erythematosus. Biomed Res Int. 2019;2019:7948687.","journal-title":"Biomed Res Int"},{"key":"6077_CR9","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.7150\/jca.29170","volume":"10","author":"W Xue","year":"2019","unstructured":"Xue W, Yan D, Kan Q. Interleukin-35 as an emerging player in tumor microenvironment. J Cancer. 2019;10:2074\u20132082.","journal-title":"J Cancer"},{"key":"6077_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.13044","volume":"157","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang Y, Wang Q, et al. Interleukin-35 in immune-related diseases: protection or destruction. Immunology. 2019;157:13\u201320.","journal-title":"Immunology"},{"key":"6077_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fcimb.2017.00472","volume":"7","author":"X Shao","year":"2017","unstructured":"Shao X, Ma J, Jia S, Yang L, Wang W, Jin Z. Interleukin-35 suppresses antiviral immune response in chronic hepatitis B virus infection. Front Cell Infect Microbiol. 2017;7:472.","journal-title":"Front Cell Infect Microbiol"},{"key":"6077_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.intimp.2017.06.015","volume":"50","author":"S Liu","year":"2017","unstructured":"Liu S, Zhang Q, Shao X, Wang W, Zhang C, Jin Z. An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection. Int Immunopharmacol. 2017;50:87\u201394.","journal-title":"Int Immunopharmacol"},{"key":"6077_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3389\/fimmu.2019.01032","volume":"10","author":"L Yang","year":"2019","unstructured":"Yang L, Shao X, Jia S, Zhang Q, Jin Z. Interleukin-35 dampens CD8(+) T cells activity in patients with non-viral hepatitis-related hepatocellular carcinoma. Front Immunol. 2019;10:1032.","journal-title":"Front Immunol"},{"key":"6077_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12985-019-1158-0","volume":"16","author":"L Yang","year":"2019","unstructured":"Yang L, Jia S, Shao X, et al. Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim\/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection. Virol J. 2019;16:48.","journal-title":"Virol J"},{"key":"6077_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.intimp.2019.02.048","volume":"70","author":"DK Teng","year":"2019","unstructured":"Teng DK, Liu Y, Lv YF, et al. Elevated interleukin-35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection. Int Immunopharmacol. 2019;70:252\u2013259.","journal-title":"Int Immunopharmacol"},{"key":"6077_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/CS20140511","volume":"129","author":"X Li","year":"2015","unstructured":"Li X, Tian L, Dong Y, et al. IL-35 inhibits HBV antigen-specific IFN-gamma-producing CTLs in vitro. Clin Sci (Lond). 2015;129:395\u2013404.","journal-title":"Clin Sci (Lond)"},{"key":"6077_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/hum.2017.171","volume":"29","author":"W Wang","year":"2018","unstructured":"Wang W, Guo H, Li H, et al. Interleukin-35 gene-modified mesenchymal stem cells protect concanavalin A-induced fulminant hepatitis by decreasing the interferon gamma level. Hum Gene Ther. 2018;29:234\u2013241.","journal-title":"Hum Gene Ther"},{"key":"6077_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3389\/fphar.2018.00959","volume":"9","author":"XF Zheng","year":"2018","unstructured":"Zheng XF, Hu XY, Ma B, et al. Interleukin-35 attenuates D-galactosamine\/lipopolysaccharide-induced liver injury via enhancing Interleukin-10 production in Kupffer cells. Front Pharmacol. 2018;9:959.","journal-title":"Front Pharmacol"},{"key":"6077_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1465-9921-8-62","volume":"8","author":"MC Morissette","year":"2007","unstructured":"Morissette MC, Parent J, Milot J. Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema. Respir Res. 2007;8:62.","journal-title":"Respir Res"},{"key":"6077_CR20","doi-asserted-by":"publisher","first-page":"e954893","DOI":"10.4161\/21624011.2014.954893","volume":"3","author":"S Boegel","year":"2014","unstructured":"Boegel S, Lower M, Bukur T, Sahin U, Castle JC. A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology. 2014;3:e954893.","journal-title":"Oncoimmunology"},{"key":"6077_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.7150\/ijms.21957","volume":"15","author":"ST Cheng","year":"2018","unstructured":"Cheng ST, Yuan D, Liu Y, et al. Interleukin-35 level is elevated in patients with chronic hepatitis B virus infection. Int J Med Sci. 2018;15:188\u2013194.","journal-title":"Int J Med Sci"},{"key":"6077_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/bjc.2016.47","volume":"114","author":"YP Fu","year":"2016","unstructured":"Fu YP, Yi Y, Cai XY, et al. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection. Br J Cancer. 2016;114:767\u2013776.","journal-title":"Br J Cancer"},{"key":"6077_CR23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/cas.13535","volume":"109","author":"MX Zhang","year":"2018","unstructured":"Zhang MX, Gan W, Jing CY, et al. Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection. Cancer Sci. 2018;109:1195\u20131206.","journal-title":"Cancer Sci"},{"key":"6077_CR24","doi-asserted-by":"publisher","first-page":"45678","DOI":"10.18632\/oncotarget.10141","volume":"7","author":"J Long","year":"2016","unstructured":"Long J, Guo H, Cui S, et al. IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression. Oncotarget. 2016;7:45678\u201345686.","journal-title":"Oncotarget"},{"key":"6077_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1620\/tjem.244.123","volume":"244","author":"T Li","year":"2018","unstructured":"Li T, Huang Y, Liu P, et al. Lower plasma levels of IL-35 in patients with primary biliary cirrhosis. Tohoku J Exp Med. 2018;244:123\u2013131.","journal-title":"Tohoku J Exp Med"},{"key":"6077_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1128\/CVI.00649-14","volume":"22","author":"X Yu","year":"2015","unstructured":"Yu X, Guo R, Ming D, et al. The transforming growth factor beta1\/Interleukin-31 pathway is upregulated in patients with hepatitis B virus-related acute-on-chronic liver failure and is associated with disease severity and survival. Clin Vaccine Immunol. 2015;22:484\u2013492.","journal-title":"Clin Vaccine Immunol"},{"key":"6077_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nri.2016.69","volume":"16","author":"EC Shin","year":"2016","unstructured":"Shin EC, Sung PS, Park SH. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol. 2016;16:509\u2013523.","journal-title":"Nat Rev Immunol"},{"key":"6077_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0036-1583287","volume":"36","author":"R Moreau","year":"2016","unstructured":"Moreau R. The pathogenesis of ACLF: the inflammatory response and immune function. Semin Liver Dis. 2016;36:133\u2013140.","journal-title":"Semin Liver Dis"},{"key":"6077_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","volume":"10","author":"R Martin-Mateos","year":"2019","unstructured":"Martin-Mateos R, Alvarez-Mon M, Albillos A. Dysfunctional immune response in acute-on-chronic liver failure: it takes two to Tango. Front Immunol. 2019;10:973.","journal-title":"Front Immunol"},{"key":"6077_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10620-014-3297-x","volume":"60","author":"Y Ye","year":"2015","unstructured":"Ye Y, Liu J, Lai Q, et al. Decreases in activated CD8+ T cells in patients with severe hepatitis B are related to outcomes. Dig Dis Sci. 2015;60:136\u2013145. https:\/\/doi.org\/10.1007\/s10620-014-3297-x","journal-title":"Dig Dis Sci"},{"key":"6077_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10753-012-9525-7","volume":"36","author":"D Cao","year":"2013","unstructured":"Cao D, Xu H, Guo G, et al. Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation. 2013;36:110\u2013120.","journal-title":"Inflammation"},{"key":"6077_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4049\/jimmunol.0902761","volume":"184","author":"S Phillips","year":"2010","unstructured":"Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol. 2010;184:287\u2013295.","journal-title":"J Immunol"},{"key":"6077_CR33","doi-asserted-by":"publisher","first-page":"8941260","DOI":"10.1155\/2016\/8941260","volume":"2016","author":"J Reiser","year":"2016","unstructured":"Reiser J, Banerjee A. Effector, memory, and dysfunctional CD8(+) T cell fates in the antitumor immune response. J Immunol Res. 2016;2016:8941260.","journal-title":"J Immunol Res"},{"key":"6077_CR34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.biopha.2017.10.143","volume":"97","author":"W Yu","year":"2018","unstructured":"Yu W, Wang Y, Guo P. Notch signaling pathway dampens tumor-infiltrating CD8(+) T cells activity in patients with colorectal carcinoma. Biomed Pharmacother. 2018;97:535\u2013542.","journal-title":"Biomed Pharmacother"},{"key":"6077_CR35","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1159\/000491615","volume":"47","author":"HM Wang","year":"2018","unstructured":"Wang HM, Zhang XH, Feng MM, et al. Interleukin-35 suppresses the antitumor activity of T cells in patients with non-small cell lung cancer. Cell Physiol Biochem. 2018;47:2407\u20132419.","journal-title":"Cell Physiol Biochem"},{"key":"6077_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/03008207.2018.1552267","volume":"60","author":"MX Liu","year":"2019","unstructured":"Liu MX, Liu QY, Liu Y, et al. Interleukin-35 suppresses antitumor activity of circulating CD8(+) T cells in osteosarcoma patients. Connect Tissue Res. 2019;60:367\u2013375.","journal-title":"Connect Tissue Res"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-020-06077-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:21:00Z","timestamp":1611361260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-020-06077-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6077"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06077-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of The Second Hospital of Jilin University and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}